Drugs / Stem/progenitor cells transplantation
Stem/progenitor cells transplantation
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03772938 Comparator | Dec 2018 → Feb 2020 | Stargardt disease, age-related macular degeneration, retinitis pigmentosa | Pomeranian Medical University Szczecin | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stem/progenitor cells transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03772938 ↗ |
| Modality | Cell therapy | “autologous bone marrow-derived stem/progenitor cell transplantation” NCT03772938 ↗ |
| Route | Intravitreal | “administered as an intravitreal injection” NCT03772938 ↗ |